GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Cyclically Adjusted Book per Share

Inovio Pharmaceuticals (FRA:GBM) Cyclically Adjusted Book per Share : €18.80 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Inovio Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Inovio Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2024 was €3.718. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €18.80 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Inovio Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -2.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.60% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Inovio Pharmaceuticals was 4.80% per year. The lowest was -14.30% per year. And the median was -5.50% per year.

As of today (2024-06-14), Inovio Pharmaceuticals's current stock price is €8.77. Inovio Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €18.80. Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.47.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Inovio Pharmaceuticals was 18.50. The lowest was 0.19. And the median was 3.05.


Inovio Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Inovio Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals Cyclically Adjusted Book per Share Chart

Inovio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.40 15.67 19.05 20.51 20.07

Inovio Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.81 21.92 20.34 20.07 18.80

Competitive Comparison of Inovio Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Inovio Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Inovio Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.718/131.7762*131.7762
=3.718

Current CPI (Mar. 2024) = 131.7762.

Inovio Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 17.840 100.560 23.378
201409 17.980 100.428 23.592
201412 17.821 99.070 23.704
201503 18.823 99.621 24.899
201506 26.884 100.684 35.186
201509 28.609 100.392 37.553
201512 26.799 99.792 35.388
201603 25.494 100.470 33.438
201606 23.544 101.688 30.510
201609 21.232 101.861 27.468
201612 18.936 101.863 24.497
201703 15.914 102.862 20.387
201706 16.980 103.349 21.651
201709 18.066 104.136 22.861
201712 15.979 104.011 20.244
201803 12.124 105.290 15.174
201806 12.509 106.317 15.504
201809 11.279 106.507 13.955
201812 9.432 105.998 11.726
201903 8.448 107.251 10.380
201906 5.776 108.070 7.043
201909 3.707 108.329 4.509
201912 0.366 108.420 0.445
202003 13.719 108.902 16.601
202006 12.502 108.767 15.147
202009 19.698 109.815 23.637
202012 24.344 109.897 29.191
202103 28.006 111.754 33.024
202106 24.103 114.631 27.708
202109 21.993 115.734 25.041
202112 19.525 117.630 21.873
202203 17.081 121.301 18.556
202206 13.653 125.017 14.391
202209 12.956 125.227 13.634
202212 9.953 125.222 10.474
202303 8.498 127.348 8.794
202306 6.998 128.729 7.164
202309 5.759 129.860 5.844
202312 4.721 129.419 4.807
202403 3.718 131.776 3.718

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Inovio Pharmaceuticals  (FRA:GBM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Inovio Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.77/18.8
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Inovio Pharmaceuticals was 18.50. The lowest was 0.19. And the median was 3.05.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Inovio Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Inovio Pharmaceuticals (FRA:GBM) Business Description

Industry
Traded in Other Exchanges
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals (FRA:GBM) Headlines

No Headlines